Buy One Get One free -Llimited Time Offer X
Olmecros H 12.5/40 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Olmecros H 12.5/40 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Olmecros H 12.5/40 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Olmecros H 12.5/40 Tablet include Upper respiratory tract infection. While these are the most often observed Olmecros H 12.5/40 Tablet side effects, there are can be others also. These have been listed below. These side effects of Olmecros H 12.5/40 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Olmecros H 12.5/40 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. Warnings related to Olmecros H 12.5/40 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Olmecros H 12.5/40 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olmecros H 12.5/40 Tablet in conditions like Asthma, Allergy, Kidney Disease. Some other conditions that can be affected by Olmecros H 12.5/40 Tablet are listed in the contraindications section below.
Drug reaction of Olmecros H 12.5/40 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Olmecros H 12.5/40 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmecros H 12.5/40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmecros H 12.5/40 Tablet safe for pregnant women?
Olmecros H should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olmecros H 12.5/40 Tablet safe during breastfeeding?
Breastfeeding women can take Olmecros H as it bears very minor side effects for them.
What is the effect of Olmecros H 12.5/40 Tablet on the Kidneys?
Very few cases of side effects of Olmecros H on kidney have been reported.
What is the effect of Olmecros H 12.5/40 Tablet on the Liver?
Olmecros H is rarely harmful for the liver.
What is the effect of Olmecros H 12.5/40 Tablet on the Heart?
Olmecros H is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Olmecros H 12.5/40 Tablet unless your doctor advises you to do so -
Is this Olmecros H 12.5/40 Tablet habit forming or addictive?
No, you will not get addicted to Olmecros H 12.5/40 Tablet.
Interaction between Food and Olmecros H 12.5/40 Tablet
Taking Olmecros H 12.5/40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmecros H 12.5/40 Tablet
Consult your doctor before consuming alcohol while taking Olmecros H 12.5/40 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173